A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And Lymphomas
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Sumitomo Pharma America, Inc.
AIDS Malignancy Consortium
Jonsson Comprehensive Cancer Center
Swiss Cancer Institute
Virginia Commonwealth University
Milton S. Hershey Medical Center
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
Augusta University
Amgen
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
NYU Langone Health
M.D. Anderson Cancer Center
Mayo Clinic